Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $790.09 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $345.87 | 4 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $193.72 | 13 | $0 (2023) |
| Azurity Pharmaceuticals, Inc. | $65.26 | 4 | $0 (2024) |
| Horizon Therapeutics plc | $62.77 | 4 | $0 (2021) |
| Collegium Pharmaceutical, Inc. | $36.26 | 2 | $0 (2021) |
| PFIZER INC. | $29.45 | 2 | $0 (2021) |
| Medtronic, Inc. | $22.50 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.72 | 1 | $0 (2023) |
| Metacel Pharmaceuticals LLC | $16.54 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $76.05 | 4 | Azurity Pharmaceuticals, Inc. ($46.84) |
| 2023 | $563.06 | 19 | Boston Scientific Corporation ($316.66) |
| 2021 | $150.98 | 9 | Horizon Therapeutics plc ($62.77) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 07/26/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 05/28/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 04/29/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/22/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Gastroenterology | ||||||
| 10/19/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $18.42 | General |
| Category: Sleep | ||||||
| 10/19/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/18/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/05/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/31/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/07/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/04/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/26/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $153.09 | General |
| Category: General - Therapies_NMD | ||||||
| 07/20/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/13/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/06/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/29/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/01/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/25/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/18/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/06/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $147.24 | General |
| Category: General - Therapies_NMD | ||||||
| 01/13/2023 | Metacel Pharmaceuticals LLC | Ozobax (Drug) | Food and Beverage | Cash or cash equivalent | $16.54 | General |
| Category: Neurology | ||||||
| 12/15/2021 | Medtronic, Inc. | Vanta (Device) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/22/2021 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $19.92 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 287 | 630 | $324,590 | $47,100 |
| 2022 | 3 | 164 | 471 | $260,945 | $38,966 |
| 2021 | 4 | 274 | 606 | $299,380 | $44,876 |
| 2020 | 4 | 160 | 365 | $151,130 | $18,480 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 473 | $307,450 | $44,771 | 14.6% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 41 | 53 | $13,250 | $2,273 | 17.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 45 | 66 | $660.00 | $54.73 | 8.3% |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | Office | 2023 | 33 | 38 | $3,230 | $0.76 | 0.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 386 | $250,400 | $37,198 | 14.9% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 26 | 39 | $10,000 | $1,728 | 17.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 28 | 46 | $545.00 | $39.95 | 7.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 310 | $201,500 | $31,404 | 15.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 189 | $85,050 | $11,319 | 13.3% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 31 | 49 | $12,250 | $2,100 | 17.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 33 | 58 | $580.00 | $53.30 | 9.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 81 | 241 | $108,450 | $12,790 | 11.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 55 | $35,750 | $4,603 | 12.9% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2020 | 19 | 26 | $6,500 | $1,042 | 16.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 23 | 43 | $430.00 | $45.30 | 10.5% |
About Geetha Ajay
Geetha Ajay is a School healthcare provider based in South Ozone Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2012. The National Provider Identifier (NPI) number assigned to this provider is 1235404443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Geetha Ajay has received a total of $790.09 in payments from pharmaceutical and medical device companies, with $76.05 received in 2024. These payments were reported across 32 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($790.09).
As a Medicare-enrolled provider, Ajay has provided services to 885 Medicare beneficiaries, totaling 2,072 services with total Medicare billing of $149,422. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty School
- Location South Ozone Park, NY
- Active Since 03/21/2012
- Last Updated 03/21/2012
- Taxonomy Code 163WS0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235404443
Products in Payments
- SEGLENTIS (Drug) $193.72
- PENNSAID (Drug) $62.77
- HORIZANT (Drug) $46.84
- WaveWriter Alpha Prime 16 (Device) $45.54
- Vanta (Device) $22.50
- Nucynta (Drug) $19.92
- Horizant (Drug) $18.42
- RELISTOR (Drug) $17.72
- Ozobax (Drug) $16.54
- XTAMPZA (Drug) $16.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.